A Study to Assess Anktiva in Patients With Long Covid-19. (INTERRUPT_LC)

[V.R.T.]

@Jonathan Edwards do you think Anktiva would risk revving up T cells and making things worse in a similar fashion to Checkpoint inhibitors if your T Cell hypothesis is correct?

 

[ryanc97]

@Jonathan Edwards do you think Anktiva would risk revving up T cells and making things worse in a similar fashion to Checkpoint inhibitors if your T Cell hypothesis is correct?

I will let you now how I feel in a week.

 

[V.R.T.]

I will let you now how I feel in a week.

Oh wow! Fingers crossed it does what you're hoping for. Are you planning to take daratumumab afterwards if your nk cells go up?

 

[ryanc97]

Oh wow! Fingers crossed it does what you're hoping for. Are you planning to take daratumumab afterwards if your nk cells go up?

This is the plan, basically.

 

[V.R.T.]

This is the plan, basically.

Well, as much as I wouldn't advise anyone else to attempt this yet, I really hope this works out for you and I'll be interested to hear how it goes.

 

[Jonathan Edwards]

From what I have read the chances of Anktiva being of value in ME/CFS are way less than one in a thousand. The chances of major harmful side effects much greater than that - maybe one in fifty.

 

[Jaybee00]

That Gustavo guy is zero evidence. I thought maybe he disappeared, but I guess not.

 

[Jaybee00]

@MelbME